Stock Forecast

  Apria, Inc. ( APR) Stock. Should you Buy or Sell?    $ 37.50

0.00 (0.00 %)

Apria, Inc. Analysis

Updated on 10-09-2022
Symbol APR
Price $37.50
Beta 0.000
Volume Avg. $435.04 thousand
Market Cap $1.34 B
52 Week Range $25.01 - $40.0

Apria, Inc. opened the day at $37.50 which is 0.00 % on yesterday's close. Apria, Inc. has a 52 week high of $40.0 and 52 week low of $25.01, which is a difference of $14.99. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $1.34 B and total net profit is $1145275000 which means the company is trading at 1.17 times profit to market capitalization. Theoretically, if you were to buy Apria, Inc. for $1.34 B, it would take 15 years to get your money back. Apria, Inc. are in the Medical Instruments & Supplies space which will have a sweet spot and industry standard for net profit multiples.

Price Chart

1 D | All


Apria, Inc. Stock Forecast - Is Apria, Inc. a Buy or Sell?

DCF ScoreStrong Buy
ROE ScoreStrong Buy
ROA ScoreNeutral
DE ScoreStrong Buy
PE ScoreStrong Buy
PB ScoreStrong Buy
Overall RecommendationStrong Buy

Growth and Value

PE Ratio 22.590
Dividend Yiel 0.000
Net Profit Margin 0.057

Valuing Apria, Inc.

Price Book Value Ratio 33.491 Price To Book Ratio 33.491
Price To Sales Ratio 1.162 Price Earnings Ratio 20.511

How liquid is Apria, Inc.

Current Ratio 1.086
Quick Ratio 0.982


Debt Ratio 0.949 Debt Equity Ratio 18.516
Long Term Debt To Capitalization 0.907 Total Debt To Capitalization 0.919

Latest news about Apria, Inc.

Quipt Convertible Debenture Hedging Provides An Incredible Opportunity

Quipt Convertible Debenture Hedging Provides An Incredible Opportunity

Date : 04/04/2022

Owens & Minor launches private offering of $500 million of 8-year high-yield bonds to fund Apria acquisition

Healthcare technology company Owens & Minor Inc. OMI, +3.25% said Friday it has launched a private offering of $500 million of 8-year high-yield bonds. Proceeds will be used to fund the acquisition of Apria Inc. with any remaining money to be used for general corporate purposes.

Date : 18/03/2022

Is Apria (APR) Stock Outpacing Its Medical Peers This Year?

Here is how Apria (APR) and Actinium Pharmaceuticals (ATNM) have performed compared to their sector so far this year.

Date : 11/01/2022

Apria Inc up 25% after signing a definitive agreement with Owens & Minor

Apria Inc (NASDAQ: APR) spiked 25% after it announced that it had entered a definitive agreement with Owens & Minor (NYSE: OMI) whereby Owens would acquire its common stock shares for $37.50 per share representing a total equity value of roughly $1.45 billion.  The strategic rationale of the deal The deal is set to strengthen the […] The post Apria Inc up 25% after signing a definitive agreement with Owens & Minor appeared first on Invezz.

Date : 10/01/2022

Why Owens & Minor (OMI) Is Buying Apria (APR) For $1.45 Billion

Owens & Minor, Inc. (NYSE: OMI) announced it is buying Apria, Inc. (Nasdaq: APR) for $1.45 billion. These are the details The post Why Owens & Minor (OMI) Is Buying Apria (APR) For $1.45 Billion appeared first on Pulse 2.0.

Date : 10/01/2022

About Apria, Inc.

CEO : Mr. Daniel J. Starck
Sector : Healthcare
Industry : Medical Instruments & Supplies

Website :

Exchange : NASDAQ Global Select

Description :

Apria, Inc. provides integrated home healthcare equipment and related services in the United States. The company offers home respiratory therapies, including the supply of stationary and portable home oxygen equipment, and non-invasive ventilators; obstructive sleep apnea therapy devices comprising continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services; and negative pressure wound therapy products. It also provides a range of home medical equipment and other products, and services for patients with home care needs; and clinical and administrative support services, and related products and supplies to patients. Apria, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana. As of March 29, 2022, Apria, Inc. operates as a subsidiary of Byram Healthcare Centers, Inc.

My Newsletter

Sign Up For Updates & Newsletters